Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

Stock Analysis

KRMD Repro Med Systems Inc

Price (delayed)

$2.95

Market cap

$136.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.11

Enterprise value

$131.11M

Repro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM ...

Highlights

KRMD's EPS has surged by 61% year-on-year and by 15% since the previous quarter

The net income has surged by 60% year-on-year and by 13% since the previous quarter

The quick ratio has contracted by 40% YoY and by 11% from the previous quarter

The company's equity fell by 15% YoY and by 2.8% QoQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Website: http://www.repro-med.com

Peers: OFIX

Key stats

What are the main financial stats of KRMD

Market

Shares outstanding

46.14M

Market cap

$136.12M

Enterprise value

$131.11M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

8.29

Price to sales (P/S)

3.87

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.74

Earnings

Revenue

$35.08M

Gross profit

$22.27M

Operating income

-$5.73M

Net income

-$5.3M

EBIT

-$5.29M

EBITDA

-$4.42M

Free cash flow

-$1.81M

Per share

EPS

-$0.11

EPS diluted

-$0.11

Free cash flow per share

-$0.04

Book value per share

$0.36

Revenue per share

$0.76

TBVPS

$0.58

Balance sheet

Total assets

$27.22M

Total liabilities

$10.87M

Debt

$3.73M

Equity

$16.35M

Working capital

$11.2M

Liquidity

Debt to equity

0.23

Current ratio

2.44

Quick ratio

1.92

Net debt/EBITDA

1.13

Margins

EBITDA margin

-12.6%

Gross margin

63.5%

Net margin

-15.1%

Operating margin

-16.3%

Efficiency

Return on assets

-19.4%

Return on equity

-30.4%

Return on invested capital

-36.5%

Return on capital employed

-27.3%

Return on sales

-15.1%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

KRMD stock price

How has the Repro Med Systems stock price performed over time

Intraday

-3.59%

1 week

-6.35%

1 month

28.82%

1 year

25%

YTD

-23.38%

QTD

16.14%

Financial performance

How have Repro Med Systems's revenue and profit performed over time

Revenue

$35.08M

Gross profit

$22.27M

Operating income

-$5.73M

Net income

-$5.3M

Gross margin

63.5%

Net margin

-15.1%

KRMD's net margin has surged by 67% year-on-year and by 16% since the previous quarter

The net income has surged by 60% year-on-year and by 13% since the previous quarter

The company's operating margin rose by 48% YoY and by 15% QoQ

KRMD's operating income is up by 38% YoY and by 11% from the previous quarter

Price vs fundamentals

How does KRMD's price correlate with its fundamentals

Growth

What is Repro Med Systems's growth rate over time

Valuation

What is Repro Med Systems stock price valuation

P/E

N/A

P/B

8.29

P/S

3.87

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.74

KRMD's EPS has surged by 61% year-on-year and by 15% since the previous quarter

KRMD's price to book (P/B) is 43% higher than its 5-year quarterly average of 5.8 and 6% higher than its last 4 quarters average of 7.8

The company's equity fell by 15% YoY and by 2.8% QoQ

The P/S is 38% below the 5-year quarterly average of 6.2 and 6% below the last 4 quarters average of 4.1

The revenue has grown by 20% YoY and by 4.3% from the previous quarter

Efficiency

How efficient is Repro Med Systems business performance

Repro Med Systems's return on assets has surged by 53% YoY and by 13% QoQ

KRMD's return on sales is up by 49% year-on-year and by 16% since the previous quarter

Repro Med Systems's ROE has increased by 46% YoY and by 9% from the previous quarter

KRMD's return on invested capital is up by 17% year-on-year and by 10% since the previous quarter

Dividends

What is KRMD's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for KRMD.

Financial health

How did Repro Med Systems financials performed over time

The total assets is 150% more than the total liabilities

The quick ratio has contracted by 40% YoY and by 11% from the previous quarter

The current ratio has contracted by 39% YoY and by 8% from the previous quarter

KRMD's debt is 77% smaller than its equity

The company's equity fell by 15% YoY and by 2.8% QoQ

KRMD's debt is down by 11% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.